METASTATIC PRIMARY CENTRAL CHONDROSARCOMA
Clinical trials for METASTATIC PRIMARY CENTRAL CHONDROSARCOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC PRIMARY CENTRAL CHONDROSARCOMA trials appear
Sign up with your email to follow new studies for METASTATIC PRIMARY CENTRAL CHONDROSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for rare bone cancer
Disease control OngoingThis study tests whether combining belinostat with either guadecitabine or ASTX727 can help people with a rare bone cancer called conventional chondrosarcoma that cannot be surgically removed and has spread. The goal is to shrink or stabilize the tumors. The study enrolled 19 adu…
Matched conditions: METASTATIC PRIMARY CENTRAL CHONDROSARCOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 07:34 UTC
-
Immunotherapy shows promise for rare sarcomas in early trial
Disease control OngoingThis study tested a drug called atezolizumab in 27 people with rare cancers of the bone (chondrosarcoma) or soft tissue (clear cell sarcoma) that could not be removed by surgery or had spread. Atezolizumab is an immunotherapy that helps the body's immune system attack cancer cell…
Matched conditions: METASTATIC PRIMARY CENTRAL CHONDROSARCOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:54 UTC